Cornelius Carolin, Koverech Guido, Crupi Rosalia, Di Paola Rosanna, Koverech Angela, Lodato Francesca, Scuto Maria, Salinaro Angela T, Cuzzocrea Salvatore, Calabrese Edward J, Calabrese Vittorio
Department of Chemistry, University of Catania Catania, Italy ; Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine Messina, Italy.
Department of Biomedical Sciences, University of Catania Catania, Italy.
Front Pharmacol. 2014 Jun 10;5:120. doi: 10.3389/fphar.2014.00120. eCollection 2014.
Alzheimer's disease (AD) and osteoporosis are multifactorial progressive degenerative disorders. Increasing evidence shows that osteoporosis and hip fracture are common complication observed in AD patients, although the mechanisms underlying this association remain poorly understood. Reactive oxygen species (ROS) are emerging as intracellular redox signaling molecules involved in the regulation of bone metabolism, including receptor activator of nuclear factor-κB ligand-dependent osteoclast differentiation, but they also have cytotoxic effects that include lipoperoxidation and oxidative damage to proteins and DNA. ROS generation, which is implicated in the regulation of cellular stress response mechanisms, is an integrated, highly regulated, process under control of redox sensitive genes coding for redox proteins called vitagenes. Vitagenes, encoding for proteins such as heat shock proteins (Hsps) Hsp32, Hsp70, the thioredoxin, and the sirtuin protein, represent a systems controlling a complex network of intracellular signaling pathways relevant to life span and involved in the preservation of cellular homeostasis under stress conditions. Consistently, nutritional anti-oxidants have demonstrated their neuroprotective potential through a hormetic-dependent activation of vitagenes. The biological relevance of dose-response affects those strategies pointing to the optimal dosing to patients in the treatment of numerous diseases. Thus, the heat shock response has become an important hormetic target for novel cytoprotective strategies focusing on the pharmacological development of compounds capable of modulating stress response mechanisms. Here we discuss possible signaling mechanisms involved in the activation of vitagenes which, relevant to bone remodeling and through enhancement of cellular stress resistance provide a rationale to limit the deleterious consequences associated to homeostasis disruption with consequent impact on the aging process.
阿尔茨海默病(AD)和骨质疏松症是多因素导致的进行性退行性疾病。越来越多的证据表明,骨质疏松症和髋部骨折是AD患者中常见的并发症,尽管这种关联背后的机制仍知之甚少。活性氧(ROS)作为细胞内氧化还原信号分子正在崭露头角,参与骨代谢的调节,包括核因子κB受体激活剂配体依赖性破骨细胞分化,但它们也具有细胞毒性作用,包括脂质过氧化以及对蛋白质和DNA的氧化损伤。ROS的产生与细胞应激反应机制的调节有关,是一个受氧化还原敏感基因控制的综合、高度调控的过程,这些基因编码称为维它基因的氧化还原蛋白。维它基因编码热休克蛋白(Hsps)如Hsp32、Hsp70、硫氧还蛋白和沉默调节蛋白等蛋白质,代表了一个控制系统,该系统控制着与寿命相关的复杂细胞内信号通路网络,并参与在应激条件下维持细胞内稳态。一致地,营养抗氧化剂已通过维它基因的应激反应依赖性激活证明了其神经保护潜力。剂量反应的生物学相关性影响着那些旨在为众多疾病患者确定最佳给药剂量的策略。因此,热休克反应已成为新型细胞保护策略的重要应激反应靶点,这些策略侧重于开发能够调节应激反应机制的化合物的药理学研究。在这里,我们讨论了维它基因激活可能涉及的信号机制,这些机制与骨重塑相关,并通过增强细胞应激抗性,为限制与内稳态破坏相关的有害后果提供了理论依据,从而对衰老过程产生影响。